Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT00876993
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2009-04-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Sponsor:
Johns Hopkins All Children's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ACH-CNS-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None